Nurse Practitioner, Family · New York, NY
NPI
1710687132
Since 2023
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5 E 98th St
New York, NY, 10029
Phone (212) 241-9728
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
1,167 services
Medicare patients, 2024
179
Average age 78
Drug cost, 2024
$2.7M
851 prescriptions
Company payments, 2025
$6,530
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Foday Koroma was code 99214 (office e&m - established), 234 times for 128 patients. In total Foday Koroma billed 1,167 services in 26 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 234 | 128 | $89.03 | $21K |
| 96372 Injection Administration | Office | 100 | 31 | $8.55 | $855 |
| 96910 Skin | Office | 42 | 19 | $89.92 | $3,777 |
| 11102 Skin Biopsy | Office | 39 | 30 | $66.60 | $2,598 |
| 36415 Venipuncture Blood Collection | Office | 37 | 30 | $8.65 | $320 |
| 11103 Skin Biopsy | Office | 21 | 15 | $38.57 | $810 |
| 17000 Destruction Skin Lesion | Office | 15 | 13 | $34.55 | $518 |
| 99213 Office E&M - Established | Office | 15 | 12 | $57.68 | $865 |
By year: 2023 $14K for 805 services; 2024 $35K for 1,167 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 37 | 30 | $8.65 | $320 |
Medicare prescription drug claims, 2024
In 2024, the drug Foday Koroma prescribed most often to Medicare patients was Mometasone Furoate, with 75 prescriptions and refills. In total Foday Koroma wrote 851 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mometasone Furoate Generic | 75 | 83 | 33 | $1,515 |
| Dupixent Pen Dupilumab | 68 | 71 | 12 | $257K |
| Dupixent Syringe Dupilumab | 53 | 62 | Under 11 | $253K |
| Bimzelx Autoinjector Bimekizumab-Bkzx | 43 | 62 | Under 11 | $668K |
| Clobetasol Propionate Generic | 43 | 45 | 24 | $2,624 |
| Otezla Apremilast | 36 | 36 | Under 11 | $173K |
| Acitretin Generic | 30 | 48 | Under 11 | $21K |
| Rinvoq Upadacitinib | 30 | 36 | Under 11 | $220K |
| Siliq Brodalumab | 30 | 30 | Under 11 | $155K |
| Mycophenolate Mofetil Generic | 29 | 43 | Under 11 | $1,836 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 25 | 26 | 12 | $1,476 |
| Prednisone Generic | 25 | 37 | Under 11 | $163 |
| Mupirocin Generic | 22 | 22 | 16 | $137 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 17 | 17 | Under 11 | $154K |
| Betamethasone Dipropionate Generic | 17 | 17 | Under 11 | $1,061 |
Brand drugs: 418 claims; generic drugs: 433 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Foday Koroma $6,530 ($6,530 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $1,840.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 50 | $1,840 |
| Galderma Laboratories, L.P. GALD.SW | 14 | $686 |
| UCB, Inc. UCB.BR | 26 | $679 |
| LEO Pharma Inc. | 14 | $643 |
| Genzyme Corporation SNY | 13 | $611 |
| Arcutis Biotherapeutics, Inc. ARQT | 13 | $444 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $376 |
| Lilly USA, LLC LLY | 12 | $278 |
| Organon LLC OGN | 4 | $225 |
| Pfizer Inc. PFE | 4 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.